Cargando…
Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction
BACKGROUND: Sugammadex, a γ-cyclodextrin derivative, belongs to a new class of selective relaxant binding agents. Sugammadex was approved 10-years ago by the European medicines agency and today is used in clinical anesthesia and emergency medicine globally. In this review, indications for neuromuscu...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220468/ https://www.ncbi.nlm.nih.gov/pubmed/30400850 http://dx.doi.org/10.1186/s12871-018-0605-6 |